The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Submit to the world's largest public repository of biological and scientific information What do you want to submit? Enter a few words about your data and select an option to learn more. The Sequence Read Archive (SRA) accepts minimally-processed sequence reads from all branches of life as well as metagenomic and environmental surveys. Submit unassembled , high throughput sequencing reads. Learn more Submit Submit unassembled , high throughput sequencing reads. Submit to GenBank Review the three GenBank submission paths below to select the appropriate option for your data. Use the Submission Portal-GenBank to submit assembled nucleotide sequences, except for prokaryotic and eukaryotic genomes and transcriptomes. Learn more Submit Use the Submission Portal-GenBank to submit assembled nucleotide sequences, except for prokaryotic and eukaryotic genomes and transcriptomes. Submit assembled prokaryotic and eukaryotic genomes. Learn more Submit Submit assembled prokaryotic and eukaryotic genomes. Submit computationally assembled , transcribed RNA sequences (transcriptomes) after submitting reads to SRA. Learn more Submit Submit computationally assembled , transcribed RNA sequences (transcriptomes) after submitting reads to SRA. Resources for sequence submitters Public Health submitter guidance Best practices and recommendations for public health submitters About submission groups Learn what submission groups are, when to use them, and how to manage them BioProject and BioSample Learn more and submit. Submit human variation, phenotype data, and testing descriptions Submit human genomic variants classified for inherited diseases, cancer, or drug responses and the evidence for classification. Learn more Submit Submit human genomic variants classified for inherited diseases, cancer, or drug responses and the evidence for classification. Submit genetic tests for inherited diseases, cancer phenotypes, pharmacogenomics, complex diseases, and infectious agents, that clinicians can order from your lab. Learn more Submit Submit genetic tests for inherited diseases, cancer phenotypes, pharmacogenomics, complex diseases, and infectious agents, that clinicians can order from your lab.

Submit genetic variants and frequency data to dbSNP for SNVs and to dbVar for structural variants. Learn more Submit Submit genetic variants and frequency data to dbSNP for SNVs and to dbVar for structural variants. Submit individual-level phenotype, molecular, and sequence data from human-subject research studies, along with genomic summary results. Learn more Submit Submit individual-level phenotype, molecular, and sequence data from human-subject research studies, along with genomic summary results. Submit BioProject and BioSample Submit a research study for your sample and sequence data. Learn more Submit Submit a research study for your sample and sequence data. Submit sample/source metadata. Learn more Submit Submit sample/source metadata. Submit to other NLM resources Submit RNA-seq, ChIP-seq, and other types of gene expression and epigenomics datasets. Learn more Submit Submit RNA-seq, ChIP-seq, and other types of gene expression and epigenomics datasets. The ClinicalTrials.gov Protocol Registration and Results System (PRS) to submit clinical study and results information. Learn more Submit The ClinicalTrials.gov Protocol Registration and Results System (PRS) to submit clinical study and results information. Submit peer-reviewed manuscripts to PubMed Central (PMC), as required by the public access policies of NIH and other PMC-participating funders . Learn more Submit Submit peer-reviewed manuscripts to PubMed Central (PMC), as required by the public access policies of NIH and other PMC-participating funders . Submit chemical substances and their biological experimental results. Learn more Submit Submit chemical substances and their biological experimental results. Sequence submission FAQ What is an accession number? An accession number in bioinformatics is a unique identifier given to a DNA or protein sequence record to allow for tracking of different versions of that sequence record and the associated sequence over time in a single data repository. Because of its relative stability, accession numbers can be utilized as foreign keys for referring to a sequence object, but not necessarily to a unique sequence. All sequence information repositories implement the concept of "accession number" but might do so with subtle variation. What is an accession number? An accession number in bioinformatics is a unique identifier given to a DNA or protein sequence record to allow for tracking of different versions of that sequence record and the associated sequence over time in a single data repository. Because of its relative stability, accession numbers can be utilized as foreign keys for referring to a sequence object, but not necessarily to a unique sequence. All sequence information repositories implement the concept of "accession number" but might do so with subtle variation. What happens after my data is submitted? Please read the NLM GenBank and SRA Data Processing document which describes how sequence data are processed and made available to the public, responsibilities of the data submitter, responsibilities of NCBI, and defines data status. You may write to info@ncbi.nlm.nih.gov if you have questions about your submitted data or if you have questions about the document. What happens after my data is submitted? Please read the NLM GenBank and SRA Data Processing document which describes how sequence data are processed and made available to the public, responsibilities of the data submitter, responsibilities of NCBI, and defines data status. You may write to info@ncbi.nlm.nih.gov if you have questions about your submitted data or if you have questions about the document.